The MOZART® System - margin assessment for breast surgery


The only breast specimen imaging system that uses 3D tomosynthesis to identify surgical margins in three axes, and facilitates lower re-excisions by visualizing more information than 2D imaging.

Schedule Virtual Demo
See Clinical Proof

The MOZART System – margin assessment for the operating room

The MOZART iQ® 3D Specimen Radiography System

The MOZART iQ 3D Specimen Radiography System is a major advancement in breast cancer margin assessment from KUBTEC. It uses intraoperative 3D tomosynthesis X-ray technology, the gold standard for diagnostics mammography as well as amorphous selenium direct capture imaging technology, to provide a clear view of surgical margins. This new system is exclusively available in the US and Canada.

3D specimen tomosynthesis technology has been shown in independent clinical studies, published in peer-reviewed journals, to deliver key benefits when used in the OR.

  • Re-excisions - In a UT Southwestern study of 446 breast cancer surgeries, the MOZART system "decreased re-excision rates by more than half" compared to the Hologic Trident® System1.
  • Tissue Preservation - In a MD Anderson study of 99 breast cancer surgeries the authors concluded that use of the MOZART system “decreases the amount of additional tissue excised unnecessarily.”2
  • Efficiency - In a Rush Medical study, the use of the MOZART system “saved an average of 7.6 minutes per surgery and a decrease in OR cost of $284.62 per case” for wire‐localized segmental mastectomies3.

With an integrated HD camera, the MOZART iQ System automatically creates optical images enabling you to visually orient your specimen accurately, every time, right in the OR. What's more, the MOZART iQ System includes the proprietary Image Blender™ which combines your X‑ray and optical images for a comprehensive view of your specimen’s anatomy. Innovative incorporation of voice control enables you to operate the system without breaking scrub.

The MOZART Specimen Tomosynthesis System

The MOZART® 3D Specimen Tomosynthesis System

The MOZART System from KUBTEC is a major advancement in the surgical treatment of breast cancer. The System uses tomosynthesis, the gold standard for diagnostic mammography, to enable surgeons and radiologists to accurately detect positive margins in breast cancer patients undergoing segmental mastectomy2, intraoperatively, right there in the OR.

3D specimen tomosynthesis technology has been shown in independent clinical studies, published in peer-reviewed journals, to deliver key benefits when used in the OR.

  • Re-excisions - In a UT Southwestern study of 446 breast cancer surgeries, the MOZART system "decreased re-excision rates by more than half" compared to the Hologic Trident® System1.
  • Tissue Preservation - In a MD Anderson study of 99 breast cancer surgeries the authors concluded that use of the MOZART system “decreases the amount of additional tissue excised unnecessarily.”2
  • Efficiency - In a Rush Medical study, the use of the MOZART system “saved an average of 7.6 minutes per surgery and a decrease in OR cost of $284.62 per case” for wire‐localized segmental mastectomies3.

With an integrated HD camera, the MOZART System automatically creates optical images enabling you to visually orient your specimen accurately, every time, right in the OR. What's more, the MOZART System includes the proprietary Image Blender™ which combines your X‑ray and optical images for a comprehensive view of your specimen’s anatomy. Innovative incorporation of voice control enables you to operate the system without breaking scrub.

The MOZART® Supra Specimen Tomosynthesis System

The MOZART Supra® 3D Specimen Radiography System

With its large 23 cm x 29 cm detector, the MOZART Supra System provides 3D imaging for breast surgery and pathology specimens of all sizes. 3D tomosynthesis technology is a major advancement within the gross room and operating room providing the accurate way to view the anatomy of mastectomies, lumpectomies, bone, and all tissue types.

In the operating room, the MOZART Supra System provides all of the benefits of the MOZART System by identifying surgical margins in three axes, and facilitates lower re-excisions by visualizing more information than 2D imaging including the capability of accepting full mastectomy specimens.

Particularly for the gross room, the MOZART Supra System features the proprietary Image Blender™ an essential tool that helps reduce turnaround time for the patient specimens. The Image Blender™ combines your X‑ray and optical images for a comprehensive view of your specimen's anatomy.

The proprietary Automagnification feature takes the guesswork out of specimen magnification and eliminates the use of manual magtrays.

Case study

View for View, 3D Specimen Tomosynthesis Provides More Data Than 2D Specimen Mammography

In this webinar, Dr. Cary Kaufman FACS, discusses how the MOZART System assists in reducing re‑excisions, and ensuring patient satisfaction the first time around.

Taking the Guesswork out of Intraoperative Margin Management: A Breast Surgeon's Use of 3D Tomosynthesis with Cary Kaufman, MD, FACS Associate Clinical Professor of Surgery Bellingham Regional Breast Center

Contact Us

Contact us to see the MOZART System and its state-of-the-art, 3D margin assessment technology in action.

Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

References

  1. Natalia Partain, MD, et al. Differences in Re-excision Rates for Breast-Conserving Surgery Using Intraoperative 2D Versus 3D Tomosynthesis Specimen Radiograph. Ann Surg Oncol 2020: Published online Aug 01, 2020
  2. Ko Un Park, MD, et al. Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery. Ann Surg Oncol 2019:26:1720-28.
  3. Hannah W. Kornfeld BA, et al. The temporal and financial benefit of intraoperative breast specimen imaging: A pilot study of the Kubtec MOZART. wileyonlinelibrary.com/journal/tbj Breast J. 2019;25:766–768
The referenced studies have not been reviewed by the FDA.